Maiju Aspegren’s Post

Welcome to the Index Ventures family, Nourish! Earlier this week, we announced our $35M investment in Nourish’s Series A, led by Damir Becirovic and Paris Heymann. Nourish enables tens of thousands of patients across all 50 states to virtually receive personalized support from hundreds of registered dietitians. There clearly aren’t many bigger problems to solve right now. Healthcare is one of the largest, most complex and most significant verticals, still operating in a largely analogue way. And right now, a whole range of factors are converging to transform this $5 trillion US market. 🛍️ Changing consumer preferences 📱 The rise of telehealth 💊 Game-changing drug discoveries 🤖 AI adoption 👵 An aging population This is the industry’s ecommerce moment. And we’re excited to support some of the world’s most ambitious founders as they take on healthcare’s biggest challenges. For more on our “why now” for healthcare, highly recommend reading Paris’ latest article on the Index blog (I’ll drop the link below). Congratulations and welcome to Stephanie Liu,  Aidan Dewar and Sam Perkins.

🚀 The key contributor to my chart on Tuesday focused on #YTD venture funding in Digital Health across Europe was the significant Flo Health Inc. deal disclosed at the very end of July. Flo Health, a pioneering #DigitalHealth venture focused on #womenshealth, announced a substantial USD 200 million Series C #funding round led by General Atlantic, a #US investor. This round has elevated Flo Health to a #valuation of USD 1 billion, a figure that surprised many industry observers. Founded in 2016 in the #UK by Dmitry Gurski and Yuri Gurski, Flo Health has rapidly become a prominent player in the women's health sector. Our #AlphaForecaster positions Flo Health significantly ahead of its peers (see slide 6 for further details). For those keen on delving deeper, a detailed #profile of Flo Health is being shared to provide further context. Despite the impressive #valuation, it is worth noting that this aligns with current market trends observed by Galen Growth | Insights You Can Trust. We do not regard this announcement as a potential return to a frothy investment environment. Stay informed. Stay ahead. Together, let's shape the future of healthcare. 🌟

At HealthX Ventures, we're committed to supporting companies that solve real, human challenges in healthcare. Bento (gobento.com), co-founded by Mick Ebeling and Adam Dole, is one of those companies. Instead of following traditional healthcare models, Bento began with a unique question: How can we truly support people facing food insecurity with solutions that are dignified and effective? By focusing on the needs of those they aim to serve, Bento developed a model that not only aligns with existing funding but fills critical gaps in how communities receive food assistance. Their person-centered approach transforms food insecurity support by leveraging technology to provide access and respect for those who need it most. Learn more about why HealthX invested in Bento in our latest blog by Kristi Ebong: https://lnkd.in/grpJdhDM #HealthXVentures #SocialImpact #DigitalHealth #HealthTech #FoodInsecurity #HealthcareInnovation

The latest BHI E-Newsletter is live! This week we are sharing stories including: 🩺 United Therapeutics Corporation announces the first successful transplant of a UThymoKidney™ into a living person, marking several historic milestones in transplantation. 💊 Gain Therapeutics reports positive results from the Phase 1 clinical trial of GT-02287, a therapy for GBA1 Parkinson’s Disease, showing good safety and tolerability profiles. 🚀 VIPC | Virginia Innovation Partnership Corporation (VIPC) appoints Joe Benevento as President & CEO to lead strategic initiatives driving innovation growth across Virginia. 📈 Alexandria Real Estate Equities, Inc. predicts a rebound in biotech investments, citing positive signs of recovery and strong performance in the sector. 💉 NIH's Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs offer over $1.3 billion annually to fund U.S. startups and support innovative healthcare solutions. 🏆 Association of University Research Parks (AURP) wins Stage One of the SBA's 2024 Growth Accelerator Fund Competition, receiving $50,000 for fostering entrepreneurship and R&D. 🌍 PitchBook ranks the world's top startup cities based on the size and maturity of their startup networks, aiding founders, operators, and investors in decision-making. ⚖️ Venable LLP is named to American Lawyer magazine’s 2024 Am Law 100 list, ranking #64 based on 2023 gross revenue. 🔬 Deloitte acquires Gryphon Scientific LLC to enhance its security, science, and public health capabilities, leveraging Gryphon's expertise in biosafety, biosecurity, and AI-driven solutions. All this and more at https://lnkd.in/es-Yst3E

Oviva, a digital platform serving as a diet & lifestyle coach, has secured a total of $113 million in funding! 🚀 Since its founding in 2014 by Kai Eberhardt, Manuel Baumann, and Mark Jenkins, the company has brought together certified dietitians, health systems, and insurers to help people get healthier. 💡 New companies using food as medicine are changing the game! 🥗 Some even customize meals for your health needs, like a prescription from a doctor. In my latest newsletter I delve into the Food-as-Medicine Industry highlighting 8 startups that have collectively raised + $400 million, link here 👉 https://lnkd.in/eMZj3ua5 Enjoy the read! #foodasmedicine, #futureofhealth, #healthtech

Swedish health tech innovator Yazen has just secured a €19.5M Series A, led by Evli Growth Partners and Helsana HealthInvest, with support from Almaz Capital, Yabeo, Luminar Ventures, and Aggregate Media. Founded in 2021 by healthcare experts from Min Doktor, Yazen provides a digital service that combines GLP-1 weight-loss and diabetes medications with personalized lifestyle guidance. With 20K active users who’ve collectively lost over 200 tons of weight, Yazen is already making a significant impact. This new funding fuels Yazen’s international expansion, with soft launches in the Netherlands, Norway, and Spain, plus pilot projects in the UK and Germany. Rather than opening new offices, Yazen employs healthcare professionals with dual certifications, reducing operational costs and enhancing scalability. As CEO and co-founder Fredrik Meurling highlights, this model supports expansion across Europe and lets Yazen scale its impact responsibly. Currently profitable in Sweden with €18M in annual recurring revenue, Yazen is paving the way as a European leader in GLP-1 treatment pathways, even as supply chain challenges persist. While GLP-1 drug demand has caused shortages, Meurling believes these issues will ease over time, especially as the urgency around global obesity — now affecting a billion people — continues to grow. For Yazen, the potential is clear. Meurling envisions a future with new payers, from corporate clients to public funders, recognizing the value of holistic, digitally-driven obesity treatment. Yazen’s commitment to combining medical treatment with lifestyle coaching positions it as a unicorn in the making, poised to redefine the obesity treatment landscape in Europe and beyond. https://lnkd.in/fzpnPPW #healthtech #digitalhealth #obesitytreatment #startupfunding #europeanstartups #healthcareinnovation #telemedicine #weightloss #medtech #healthcare #innovation #patientcare #healthstartups #healthinvestment #globalhealth #weightmanagement #obesitycare #digitaltransformation #healthsolutions #telehealth #medicalinnovation #chronicdisease #healthrevolution #healthcarestartups Yazen Health

Adopting Tech -led solutions in Agriculture and Healthcare sectors will improve the productivity and effiency in both sectores. DIMO as a trailblazer in bringing latest Technologies to Sri Lanka has introduced enormous technologies to the nation. Explore latest technological advancments company introduced through below link

We're thrilled to announce the release of the Digital Health Pharma Playbook by DayOne from Basel Area Business & Innovation, offering key insights into building partnerships between pharma and digital health startups. Abhishek Shah, Co-CEO of TruDoc , along with Jan Beger, Jubin Shah, PhD, Cécile Tardy-Srinivasan, Lluc Diaz, Christophe Dufour, Sumit Jamuar, and Dr. Rayna Patel, contributed to shaping this essential guide for innovation in healthcare. Discover how collaboration is transforming health outcomes, Link to the playbook in the comments. #DigitalHealth #PharmaInnovation #HealthcarePartnerships #HealthTech #StartupCollaboration #DayOneAccelerator #HealthcareTransformation #BaselAreaInnovation #DigitalHealthEcosystem #HealthInnovation

"The success or failure of a product is often decided before launch.” Dan Feldman, EVERSANA   The importance of defining a clear launch strategy was highlighted today through the fourth module within the 10xHealth scaleup program, focusing on market expansion and internationalisation. It is a pleasure to have a large group of experts – Mike Ryan, Edward Bellringer, David Byram, Venelin Milev, Alberta M.C. Spreafico, PhD, MBA, Dan Feldman, James May, and Marty Culjat from EVERSANA plus Mark Kroes from the company Global Data Support – share their deep insights during the one-day workshop with the 10xHealth participating companies. EVERSANA is an independent leading provider of global services to the life sciences industry. 🔬🌎   Insights from today’s module include: 👉 In-depth knowledge related to taking a life science product to the market, illustrated by real life cases and own experiences from several years in the industry.  👉 The crucial similarities and differences in launching in different markets, with special focus on the EU and the US complemented with some insights into Asia.  👉 The importance in having the complete picture in mind from the beginning, especially the commercial dimension, alongside product development and the path to regulatory approval.   #10xHealth is a scaleup program dedicated to supporting life science growth companies, and is jointly developed by SmiLe Venture Hub and Medicon Village with partial financing from the European Regional Development Fund. Companies participating in the 2024 10xHealth pilot include Uman Sense, Paindrainer AB, Iconovo AB, NanoEcho AB, Cyxone, and Neola Medical.   To find out more about 10xHealth: https://10xhealth.se/

It is probably my last announcement this year as NCBR Investment Fund ASI S.A. invested once again in Saventic Health! 🚀 Following our initial investment in 2022, we backed once again to fuel further growth and enhance people's life across globe! Saventic Health algorithms support doctors in Brazil, Canada, France, Germany and Poland, with going to Austria, Italy, Spain, and Sweden in near future. Did I mention that Saventic’s algorithms are registered as medical devices across the European Union.     Since founding in 2019 Saventic Health has helped over 200 patients to accurately diagnose them and works with 11 among 30 global pharma companies. Once again, we invested along 4growth VC with Kluz Ventures as a new investor.     Szymon Piatkowski Krzysztof Bachta Marcin Jaszczuk Tomasz Biłous Piotr Soroka Wojciech Proszak Ilona Mosiołek Artur Kluz Marcin Molo Marcin Bielówka #HealthTech #AI #RareDiseases #StartupFunding #MedTech #innovation #Poland #Global #Biotech #Pharma #algorithms #growth #orphandiseases #BridgeAlfa #datascience #BigPharma